{
  "chapter": "Renal Pharmacology-Previous Year Questions",
  "questions": [
    {
      "q_no": 1,
      "question": "Which of the following drugs is appropriate for treating a 75-year-old woman with urinary incontinence triggered by stress, such as coughing?",
      "options": {
        "A": "Ipratropium",
        "B": "Tolterodine",
        "C": "Telenzepine",
        "D": "Tropicamide"
      },
      "correct_answer": "B",
      "explanation": "specifically targets muscarinic receptors in the bladder. It reduces involuntary bladder contractions by blocking these receptors, which can help in managing symptoms of urinary incontinence, particularly urge incontinence. Use in Stress Incontinence: While tolterodine is primarily used to treat urge incontinence, it can sometimes be beneficial in mixed incontinence cases where urgency is also a factor. However, the first-line treatment for pure stress incontinence typically involves non-pharmacological approaches like pelvic floor exercises. Pharmacologically, stress incontinence is less commonly treated with medications, but if there is an urgency component, tolterodine may be considered. Incorrect Options: Option A - Ipratropium: Mechanism of Action: Ipratropium is an anticholinergic drug used mainly as a bronchodilator in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. It has no role in the management of urinary incontinence. Option C - Telenzepine: Mechanism of Action: Telenzepine is a selective M1 muscarinic receptor antagonist used mainly for reducing gastric acid secretion in conditions like peptic ulcer disease. It is not indicated for treating urinary incontinence. Option D - Tropicamide: Mechanism of Action: Tropicamide is an antimuscarinic drug used primarily as a mydriatic agent to dilate the pupil for ophthalmic examinations. It has no effect on bladder function and is not used for urinary incontinence.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 2,
      "question": "What is the preferred initial treatment for a 4-year-old boy who initially had facial swelling but now has experienced total body swelling involving the face, abdomen, scrotum, and feet, and has a urinalysis showing 4+ protein and a urine protein: creatinine ratio of 3?",
      "options": {
        "A": "Prednisolone",
        "B": "Cyclophosphamide",
        "C": "Levamisole",
        "D": "Cyclosporine"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer A- Prednisolone Explanation: The boy is likely suffering from nephrotic syndrome due to minimal change disease, with prednisolone being the initial treatment of choice. Prednisolone, a synthetic glucocorticoid with intermediate potency, is effective in managing minimal change disease. Duration of Action Glucocorticoid Potency Effects/Uses Short (8-12 hrs) Hydrocortisone Low Physiological replacement therapy, adrenal insufficiency, anti-inflammatory Intermediate (12-36 hrs) Cortisone Anti-inflammatory, rheumatic disorders Prednisone Intermediate Anti-inflammatory, immunosuppressive, rheumatic disorders, asthma, autoimmune diseases Minimal change disease Prednisolone Intermediate to Long Methylprednisolone Intermediate to High Anti-inflammatory, immunosuppressive, severe inflammatory conditions, multiple sclerosis. Long (36-72 hrs) Dexamethasone High Anti-inflammatory, immunosuppressive, severe inflammatory conditions, cerebral edema. Betamethasone Fludrocortisone Mineralocorticoid activity, adrenal insufficiency, salt-wasting disorders. Incorrect Options: Cyclophosphamide (Option B) is used in cases of steroid-resistant nephrotic syndrome or in certain secondary forms of nephrotic syndrome, but it's not the first choice in typical steroid-sensitive cases. Levamisole (Option C) can be used as an a djunctive therapy for steroid-sensitive nephrotic syndrome if relapses occur, but is not usually the initial treatment. Cyclosporine (Option D) is used in cases of steroid-resistant nephrotic syndrome or for severe disease, but it is not typically the first choice in steroid-sensitive cases. Reference: K D Tripathi, Essentials of Medical Pharmacology, 8th Edition, Page 309",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 3,
      "question": "Which of the following is a true statement regarding Aliskiren?",
      "options": {
        "A": "It is indicated in diabetes mellitus",
        "B": "It is used in the treatment of diabetic nephropathy",
        "C": "It increases renin levels",
        "D": "It increases aldosterone levels"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - It increases renin levels Explanation: Aliskiren is a direct renin inhibitor that inhibits plasma renin activity and the RAAS, leading to increased plasma renin levels. By inhibiting renin activity, it disrupts the renin-angiotensin-aldosterone system (RAAS), leading to a feedback increase in renin levels due to reduced angiotensin II. (Option C) Aliskiren is not indicated for use in diabetes mellitus or diabetic nephropathy due to the risk of adverse effects such as hyperkalemia and renal impairment. (Option A) It decreases aldosterone levels by reducing angiotensin II production, which stimulates aldosterone release. (Option D) Aliskiren MOA Direct renin inhibitor thus blocks the formation of angiotensin 1 , which inhibits the RAAS and thus reduces BP. Uses Hypertension Heart failure Diabetic nephropathy Off-label use: Proteinuria and resistant hypertension Side effects Diarrhoea Flu-like symptoms Peripheral edema Reference: Aliskiren - PMC",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Renal_Pharmacology-Previous_Year_Questions_Q3_exp.jpg",
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 4,
      "question": "Which drug is most suitable for treating edema in a patient with heart disease and presenting with breathlessness with rales?",
      "options": {
        "A": "ACE inhibitors",
        "B": "Na-K-2Cl symporter inhibitor in the loop in Henle",
        "C": "Na-Cl symporter inhibitor in DCT",
        "D": "Aldosterone blocker in DCT"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Na-K-2Cl symporter inhibitor in the loop in Henle Explanation: The most suitable drug for treating edema with heart disease presenting with pulmonary edema. Loop diuretic MOA Inhibit the Na-K-2Cl symporter in the thick ascending loop of Henle, increasing the excretion of sodium, chloride, and water, resulting in diuresis and reduction of edema. Drugs Furosemide, Bumetanide Uses Acute pulmonary edema Chronic heart failure Hypercalcemia Side effects Hypokalemia, Ototoxicity, Metabolic alkalosis, Hyperglycemia, Hyperuricemia ACE inhibitors (angiotensin-converting enzyme inhibitors) (Option A) are commonly used in the treatment of heart disease, but they primarily target the renin-angiotensin-aldosterone system (RAAS) to reduce blood pressure and improve cardiac function. While they can have some mild diuretic effects, they are not the first-line choice for managing edema and pulmonary edema. Na-Cl symporter inhibitors in the distal convoluted tubule (DCT) (Option C), such as thiazide diuretics (e.g., hydrochlorothiazide), are effective in reducing blood pressure but have limited efficacy in treating edema. They primarily promote sodium and water excretion in the DCT but are less potent than loop diuretics. They are not preferred for acute management of pulmonary edema Aldosterone blockers (Option D) , such as spironolactone and eplerenone, act on the aldosterone receptors in the distal tubules to inhibit the effects of aldosterone, a hormone that promotes sodium and water retention. While aldosterone blockers can be beneficial in some cases of heart failure, they are typically used as adjunct therapy rather than as the primary treatment for edema. Reference: Goodman and Gilman Pharmacological Basis of Therapeutics, 14th Edition, Page 562",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 5,
      "question": "Which of the following is the drug of choice for central diabetes insipidus?",
      "options": {
        "A": "Insulin",
        "B": "Desmopressin",
        "C": "Diazoxide",
        "D": "Chlorpropamide"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Desmopressin Explanation: Desmopressin is the drug of choice for central diabetes insipidus. Desmopressin DDAVP, or desmopressin, is a synthetic analogue of vasopressin MOA Acts on V2 receptors located in renal tubules, which increases water reabsorption in the renal tubule Uses Diabetes insipidus(central) Nocturnal Enuresis Route Nasal or intravenous, as the oral route is less efficacious due to getting metabolised by trypsin in the gut Side effects Hyponatremia Cerebral edema Fluid overload Insulin (Option A) is primarily used to manage diabetes mellitus, a condition characterised by high blood sugar levels due to insulin deficiency or resistance. Central diabetes insipidus on the other hand, is a water balance disorder caused by a vasopressin deficiency (also known as antidiuretic hormone or ADH).\\ Diazoxide (Option C) is a medication primarily used to treat hypoglycemia caused by excessive insulin secretion, such as in certain forms of hyperinsulinism. It works by opening potassium channels in the beta cells of the pancreas, inhibiting insulin release. It does not directly affect vasopressin/ADH or the treatment of central diabetes insipidus. Chlorpropamide (Option D) is an oral medication that belongs to the sulfonylurea class of drugs and is primarily used to lower blood sugar levels in type 2 diabetes mellitus. It stimulates insulin secretion from the pancreas and enhances the effectiveness of insulin in peripheral tissues. Reference: Goodman & Gilman Pharmacological Basis of Therapeutics, 14th Edition, Page 581",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 6,
      "question": "A patient on lithium developed hypertension. He was started on thiazides for hypertension. After a few days, he developed coarse tremors and other symptoms suggestive of lithium toxicity. Explain the likely mechanism of this interaction:",
      "options": {
        "A": "Thiazide inhibits the metabolism of Lithium",
        "B": "Thiazide act as an add-on drug to Lithium",
        "C": "Thiazide increases the tubular resorption of Lithium",
        "D": "Thiazide causes water loss, thereby increasing the Lithium level"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Thiazide increases the tubular resorption of Lithium Explanation: Thiazide increases the tubular resorption of Lithium, which can lead to lithium toxicity. Thiazide use is accompanied by sodium loss, which is compensated in a few days by increased reabsorption of Nat in the proximal tubule. The kidney handles both lithium and sodium in the same way Along with sodium reabsorption, there will also be an increase in the reabsorption of lithium, resulting in decreased excretion of lithium. Thiazides MOA Reduces the reabsorption of sodium and chloride ions, leading to increased excretion of these ions in the urine Uses Hypertension Edema (Congestive cardiac failure, Cirrhosis and renal dysfunction) Adverse effects Electrolyte imbalances Hypokalemia Hyponatremia Hypomagnesemia Hypercalcemia Increased uric acid Hyperglycemia Hyperlipidemia",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 7,
      "question": "A patient who was diagnosed with ADPKD was prescribed Tolvaptan, and after a few weeks, he presented with dry mouth and increased thirst. What is the most likely cause of this presentation?",
      "options": {
        "A": "Increased free water clearance",
        "B": "V2 receptor antagonism",
        "C": "Increased renal cAMP level",
        "D": "Increase in urine osmolality"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - V2 receptor antagonism Explanation: The most likely cause of the patient's dry mouth and increased thirst after taking Tolvaptan is V2 receptor antagonism. Tolvaptan It is a medication that belongs to a class of drugs known as vasopressin receptor antagonists. MOA Blocks vasopressin receptors, specifically targeting the V2 receptors V2 receptors are located in the renal collecting ducts Blockade of V2 receptors reduces water reabsorption and promotes the excretion of free water, leading to increased urine output. Uses Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) Autosomal Dominant Polycystic Kidney Disease (ADPKD) Hyponatremia Side effects Polyuria and polydipsia Dehydration Dry mouth Hypersensitivity reactions Contraindications Hypersensitivity Concurrent use of CYP3A inhibitors - Ketoconazole, Clarithromycin Precautions Monitor serum sodium levels - adjust dose accordingly Use with caution in patients with hepatic diseases Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 582, 583",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 8,
      "question": "A patient with gout develops hypertension. The uric acid level was found to be elevated. Which of the following antihypertensives should not be used?",
      "options": {
        "A": "Hydrochlorothiazide",
        "B": "Atenolol",
        "C": "Enalapril",
        "D": "Prazosin"
      },
      "correct_answer": "A",
      "explanation": "Correct Answer: A) Hydrochlorothiazide Explanation: Thiazide diuretics such as Hydrochlorothiazide should not be used in patients with gout as thiazide can increase uric acid levels by reducing its excretion from the kidneys. MOA: Thiazide diuretics block the sodium-chloride (Na/Cl) channel in the proximal segment of the distal convoluted tubule (DCT). Blocking the Na/Cl channel reduces sodium uptake into the cells Decreases Na/K pump activity Increases sodium and water retention in the tubule lumen. Enhances calcium reabsorption via the Na/Ca channel in exchange for sodium returning to the DCT. Thiazide increases direct uric acid reabsorption in the proximal renal tubule, which increases the serum urate levels, and it may precipitate gout. Increased sodium delivery to the distal DCT and collecting tubule stimulates the aldosterone-sensitive Na/K pump.’ Atenolol (Option B) is a beta-blocker that is commonly used in the management of hypertension. It does not directly affect uric acid levels and is generally considered safe in patients with gout. Enalapril (Option C) is an angiotensin-converting enzyme (ACE) inhibitor that is commonly used for the treatment of hypertension. It does not have a direct impact on uric acid levels and is generally considered safe in patients with gout. Prazosin (Option D) is an alpha-1 adrenergic receptor blocker primarily used for the treatment of benign prostatic hyperplasia (BPH) and hypertension. It does not directly influence uric acid levels, but it is not typically used as a first-line antihypertensive medication but can be used. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 632",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 9,
      "question": "A patient who is a known case of liver cirrhosis presents with abdominal distension and swelling of the lower limbs. What is the preferred diuretic for this patient?",
      "options": {
        "A": "Triamterene",
        "B": "Eplerenone",
        "C": "Chlorthalidone",
        "D": "Furosemide"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: A) Eplerenone Explanation: For a patient with liver cirrhosis presenting with ascites and peripheral edema, the preferred diuretic is Eplerenone. Eplerenone MOA Mineralocorticoid receptor / Aldosterone antagonist resulting in natriuresis and reducing edema Uses Primary hyperaldosteronism leading to hypertension Edema associated with liver cirrhosis, congestive cardiac failure and CKD Reduced mortality in post-MI patients. Use in cirrhosis Patients with liver cirrhosis have reduced effective blood volume due to blood accumulation in the splanchnic vessels due to vasodilatation. This results in activation of RAAS and retention of salt and water - Ascites and resistance to loop diuretics. Aldosterone enters the cells in the late DCT and Collecting ducts via diffusion and binds to specific mineralocorticoid receptors in the cellular cytosol, which mediates sodium reabsorption and potassium and H+ secretion into the tubules. Eplerenone competitively blocks this MR receptor, resulting in natriuresis. Side effects Hyperkalemia No anti-androgenic effects seen Triamterene (Option A) directly inhibits renal epithelial sodium channels (ENaC) in the late distal tubule and collecting duct. It is a potassium-sparing diuretic and is generally used along with other diuretics in the treatment of hypertension and edema, as well as in the management of Liddle syndrome. It is metabolised in the liver hence triamterene toxicity may be enhanced in patients with hepatic disease. Chlorthalidone (Option C) is a thiazide-like diuretic that inhibits the Na+-Cl symporter in the early distal tubule (Early DCT)and increases the excretion of sodium and chloride. Thiazide diuretics may be used for the treatment of hypertension, heart failure, nephrolithiasis due to idiopathic hypercalciuria, and nephrogenic diabetes insipidus. Furosemide (Option D) is a loop diuretic that inhibits Na+-K+-2Cl symporter in the thick ascending limb of the loop of Henle ,resulting in increased excretion of sodium and chloride. It also has mild carbonic anhydrase inhibitory activity and also increases urinary excretion of bicarbonate and phosphate. Cirrhotic patients are often resistant to loop diuretics due to decreased secretion of the drug into tubular fluid and high aldosterone levels. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 566-569",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 10,
      "question": "A 30-year-old man joins a pilgrimage to a shrine at a mountain peak. At the summit, he develops tightness in the chest, associated with breathlessness and altered sensorium. Which of the following can be given for symptomatic relief?",
      "options": {
        "A": "Mannitol",
        "B": "Digoxin",
        "C": "Diltiazem",
        "D": "Acetazolamide"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer D - Acetazolamide Acetazolamide is a carbonic anhydrase inhibitor commonly used to prevent or treat altitude sickness, which may cause symptoms such as breathlessness and altered sensorium due to hypoxia. It helps by improving respiratory drive and decreasing the accumulation of bicarbonate, promoting acclimatization at high altitudes. Mechanism of Action of Acetazolamide in Treating Acute Mountain Sickness (AMS): Inhibits kidney carbonic anhydrase. Increases urine bicarbonate ions excretion → Metabolic acidosis. Counteracts respiratory alkalosis from high altitude hyperventilation. Improves oxygenation and alleviates AMS symptoms. Mannitol (Option A) is an osmotic diuretic that is used to reduce intracranial pressure or manage cerebral edema. It is not indicated for altitude sickness or related symptoms like breathlessness at high altitudes. Digoxin (Option B) is a cardiac glycoside used for heart failure or atrial arrhythmias. It does not address the symptoms of altitude sickness or hypoxia, such as breathlessness and altered sensorium. Diltiazem (Option C) is a calcium channel blocker used to manage hypertension or arrhythmias. It does not provide relief for altitude sickness and would not be effective for symptoms related to reduced oxygen availability at high altitudes. Reference: Harrison Principles of Internal Medicine, 21st Edition, Page 3618 Use of acetazolamide in AMS",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Renal_Pharmacology-Previous_Year_Questions_Q10_exp.png",
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 11,
      "question": "A patient was brought to the hospital following a road traffic accident. The patient is disoriented, and a CT scan of the head shows no evidence of hemorrhage but features of cerebral edema and raised intracranial pressure. Which of the following drugs can be used for the initial management of raised intracranial pressure?",
      "options": {
        "A": "Chlorthiazide",
        "B": "Mannitol",
        "C": "Acetazolamide",
        "D": "Glycerol"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Mannitol Mannitol is an osmotic diuretic that helps reduce intracranial pressure by drawing water out of the brain and into the bloodstream, thereby decreasing cerebral edema. This makes it the most appropriate choice for initial management of raised intracranial pressure. Diuretic Type Uses Notes Thiazide Diuretics Chlorothiazide (Option A) Hypertension (effective in low-grade HTN) Not suitable for acute fluid overload but can be used as an adjunct. Carbonic Anhydrase Inhibitors Acetazolamide (Option C) Glaucoma Altitude sickness - Not recommended for acute hypertension or fluid overload. Osmotic Diuretics Mannitol Reducing intracranial pressure Acute renal failure - Not used for hypertension management. Glycerol (Option D) is another osmotic agent that can reduce cerebral edema, but it is less commonly used than mannitol. Mannitol is the preferred agent due to its more predictable and potent effects on reducing ICP. Reference: KD Tripathi Essentials of pharmacology, 8th Edition, Page 625",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 12,
      "question": "Match the following Diuretics in column A to their site of action in column B Column A Column B Acetazolamide Torsemide Chlorthalidone Vasopressin Thick ascending loop of Henle Collecting duct Distal convoluted tubule Proximal convoluted tubule",
      "options": {
        "A": "A-2, B-3, C-1, D-4",
        "B": "A-3, B-4, C-2, D-1",
        "C": "A-1, B-2, C-4, D-3",
        "D": "A-4, B-1, C-3, D-2"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer: D) A-4, B-1, C-3, D-2 Explanation: 1. Acetazolamide is a carbonic anhydrase inhibitor that works in the proximal convoluted tubule of the nephron to inhibit the reabsorption of bicarbonate ions . This results in a mild diuretic effect and the excretion of excess fluids and electrolytes. 2. Torsemide is a loop diuretic that works in the thick ascending limb of the loop of Henle to inhibit the reabsorption of sodium, potassium, and chloride ions. Torsemide blocks the Na + /K + /2Cl - cotransporter, thus decreasing the amount of ions that are reabsorbed into the bloodstream and increasing the amount of ions that are excreted in the urine. 3. Chlorthalidone : This is a thiazide-like diuretic that works in the distal convoluted tubule to inhibit the reabsorption of sodium ions. By blocking the Na + /Cl - cotransporter, chlorthalidone decreases the amount of sodium that is reabsorbed into the bloodstream and increases the amount of sodium that is excreted in the urine. This results in a moderate diuretic effect. 4. Vasopressin : This is not a diuretic, but rather an antidiuretic hormone (ADH) that works in the collecting duct to increase water reabsorption . Vasopressin acts on the V2 receptor in the collecting duct to stimulate the insertion of aquaporin-2 channels into the apical membrane , which allows for the reabsorption of water. This results in a decrease in urine volume and an increase in urine concentration. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Page 562",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 13,
      "question": "Which of the following drugs increases uric acid in urine?",
      "options": {
        "A": "Colchicine",
        "B": "Febuxostat",
        "C": "Probenecid",
        "D": "Allopurinol"
      },
      "correct_answer": "C",
      "explanation": "Correct Answer C - Probenecid Probenecid is a uricosuric agent that increases the excretion of uric acid in urine by blocking the reabsorption of uric acid in the renal tubules. Uricosuric drugs Mechanism Inhibit OAPT transporter/ URAT-1 in kidney ⇒ Inhibits reabsorption ⇒ Increase excretion of uric acid Drugs 1. Probenecid: Side effects: diarrhoea, hypersensitivity, uric acid stones Contraindication: nephrolithiasis, renal failure Precaution: take plenty of oral fluids Concomitant colchicine or NSAIDs indicated in attack of gout 2. Sulphinpyrazole: Non-steroidal anti-inflammatory drug Recommended in both acute and chronic gout 3. Benzbromarone: Safe in renal failure Contraindication – Liver diseases 4. Lesinurad Drugs for acute attack of gout DOC- NSAIDS (All types) Except for aspirin and paracetamol Anti-inflammatory Colchicine (spindle poison) (Option A) MOA: microtubule inhibitor Used in acute attacks of gout and familial Mediterranean fever and is also the DOC for karyotyping Corticosteroids Intra articular injections, avoid oral route Immunosuppressive and anti-inflammatory Drugs for chronic gout Xanthine oxidase inhibitors Allopurinol (DOC) (Option D) Oxipurinol Febuxostat (Option B) MOA: Blocks xanthine oxidase enzyme → Inhibits the conversion of hypoxanthine to uric acid in the liver. Uric acid oxidase enzyme Pegloticase Rasburicase MOA: Uric acid is converted to allantoin and excreted in urine Uricosuric agents Probenecid (OptionC) Benzbromaron Sulfinpyrazone Lesinurad MOA: Inhibit OATP transporter/URAT-1 in the kidney → inhibits reabsorption of uric acid → increased excretion of uric acid. (OATP - Organic anion transport protein, URAT-1 - Uric acid transporter) Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Page 847-852. KD Tripathi Essentials of Medical Pharmacology, 8th Edition, Page 231-235.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 14,
      "question": "Four friends are planning a trip to Ladakh. During their stay, one of them began experiencing headaches, nausea, dizziness, and fatigue. Which of the following is the most appropriate treatment for this patient?",
      "options": {
        "A": "Sumatriptan",
        "B": "Promethazine",
        "C": "Scopolamine",
        "D": "Acetazolamide"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer D - Acetazolamide The chest tightness, shortness of breath, and altered sensorium at high altitude suggest mountain sickness, and Acetazolamide (carbonic acid anhydrase inhibitor) is the drug that provides relief. Mechanism in mountain sickness: Inhibits kidney carbonic anhydrase. Increases urine bicarbonate ions excretion → Metabolic acidosis. Counteracts respiratory alkalosis from high altitude hyperventilation. Improves oxygenation and alleviates AMS symptoms. Sumatriptan (Option A) is a 5-HT1B/1D Agonist (triptan) and is used for the treatment of migraine and cluster headaches. It won’t help in relieving mountain sickness symptoms. Promethazine (Option B) is a first-generation antihistamine that acts on the basal ganglia and has anticholinergic properties. It is used for its antiemetic and anti-motion sickness properties. It won’t help in mountain sickness. Scopolamine (Option C) , or Hyoscine , is a medication with anticholinergic properties. It is used as a truth serum and is the drug of choice for prophylaxis of motion sickness. It won’t help in mountain sickness. Reference: Harrison Principles of Internal Medicine, 21st Edition, Page 3618 Use of acetazolamide in AMS",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Renal_Pharmacology-Previous_Year_Questions_Q14_exp.jpg",
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 15,
      "question": "A 50-year-old woman was prescribed a diuretic by a doctor to manage hypertension. Which of the following diuretic acts on the site 'A' is marked in the given image?",
      "options": {
        "A": "Furosemide",
        "B": "Hydrochlorothiazide",
        "C": "Acetazolamide",
        "D": "Mannitol"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Hydrochlorothiazide Site A is DCT (distal convoluted tubule), at which Hydrochlorothiazide (thiazide diuretic) acts by inhibiting the reabsorption of sodium and chloride in the distal convoluted tubule of the nephron, leading to increased excretion of sodium, chloride, and water. Classification of Diuretics Class & Drugs Mechanism of action Clinical uses Side effects Carbonic anhydrase inhibitors Acetazolamide (Option C) Methazolamide Inhibit carbonic anhydrase enzyme in the proximal tubule, decreasing bicarbonate reabsorption Glaucoma, Altitude sickness Metabolic acidosis, Hypokalemia Loop diuretics Furosemide (Option A) Bumetanide Inhibit the Na-K-2Cl symporter in the thick ascending loop of Henle Acute pulmonary edema, Chronic heart failure, Hypercalcemia Hypokalemia, Ototoxicity, Metabolic alkalosis, Hyperglycemia, Hyperuricemia Thiazide diuretics Hydrochlorothiazide (Option B) Chlorthalidone Inhibit sodium reabsorption in the distal convoluted tubule Hypertension, Edema Hypokalemia, Hyponatremia, Hyperglycemia Hyperuricemia Potassium-sparing Spironolactone Amiloride Inhibit sodium channels in the distal nephron or block aldosterone receptors Heart failure, Hyperaldosteronism Hyperkalemia, Gynecomastia (for Spironolactone)",
      "image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Renal_Pharmacology-Previous_Year_Questions_Q15_q.png",
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 16,
      "question": "A female patient complains of swelling and pain in her great toe. Her uric acid level is found to be high. A drug that reduces uric acid levels is prescribed. Which of the following enzymes should the drug inhibit?",
      "options": {
        "A": "Urease",
        "B": "Homogentisate oxidase",
        "C": "Lysyl oxidase",
        "D": "Xanthine oxidase"
      },
      "correct_answer": "D",
      "explanation": "Correct Answer D - Xanthine oxidase Xanthine oxidase , involved in Purine Metabolism by converting purines to uric acid in the liver, is targeted by medications like allopurinol and febuxostat to lower uric acid levels in the treatment of gout and hyperuricemia. Urease (Option A) breaks down urea, unrelated to uric acid metabolism. Homogentisate oxidase (Option B) relates to phenylalanine and tyrosine metabolism, not uric acid. Lysyl oxidase (Option C) is involved in collagen and elastin cross-linking, unrelated to uric acid metabolism. Reference: KD Tripathi Essentials of Medical Pharmacology, 8th Edition, Page 231-235.",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Renal_Pharmacology-Previous_Year_Questions_Q16_exp.jpg",
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 17,
      "question": "A patient was started on dialysis, and he developed disequilibrium. Which of the following drugs should be started?",
      "options": {
        "A": "Ethacrynic acid",
        "B": "Mannitol",
        "C": "Bumetanide",
        "D": "Nesiritide"
      },
      "correct_answer": "B",
      "explanation": "Correct Answer B - Mannitol Mannitol is used in the treatment of dialysis disequilibrium syndrome. Excessively removing solutes from the extracellular fluid by hemodialysis results in a reduction in the osmolality of extracellular fluid. Consequently, water moves from the extracellular compartment into the intracellular compartment, causing hypotension and CNS symptoms (headache, nausea, muscle cramps, restlessness, CNS depression, and convulsions). Osmotic diuretics increase the osmolality of the extracellular fluid compartment and thereby shift water back into the extracellular compartment. Mannitol is an osmotic diuretic that acts by increasing the osmolarity of the glomerular filtrate, inhibiting water reabsorption. Use: Cerebral edema, acute glaucoma, and dialysis disequilibrium syndrome. Side effects: Dehydration, electrolyte imbalance. Ethacrynic acid (Option A) and Bumetanide (Option C) are loop diuretics that inhibit the Na-K-2Cl symporter in the thick ascending loop of Henle. They are used in cases of acute pulmonary edema, chronic heart failure, and hypercalcemia. Nesiritide (Option D) is a recombinant human BNP (B-type Natriuretic Peptide), acts by increasing the levels of cyclic GMP, promoting vasodilation and natriuresis. It does not act on RAAS or NEP pathways. Reference: Goodman and Gilman’s Pharmacological Basis of Therapeutics, 14th Edition, Page 564",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 18,
      "question": "Which of the following diuretics is matched correctly with its primary site of action? 1) Osmotic diuretics - Distal convoluted tubule. 2) Thiazide diuretics - Proximal convoluted tubule 3) Carbonic anhydrase inhibitors - Proximal convoluted tubule 4) Potassium-sparing diuretics - Collecting duct.",
      "options": {
        "A": "1, 2, and 3",
        "B": "3 and 4",
        "C": "2, 3, and 4",
        "D": "1 and 2."
      },
      "correct_answer": "B",
      "explanation": "the loop of Henle, not the distal convoluted tubule. Thiazide diuretics – It mainly acts on the Distal convoluted tubule; the proximal convoluted tubule may be a secondary site of action. Carbonic anhydrase inhibitors – Proximal convoluted tubule. Potassium-sparing diuretics - Collecting duct. Incorrect Options: Options A, C, and D are incorrect.",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 19,
      "question": "Which of the following is the mechanism of action of thiazides in DCT?",
      "options": {
        "A": "Blockade of Na Cl symporter",
        "B": "Blockade of Na K 2Cl symporter",
        "C": "Blockade of aldosterone receptors",
        "D": "Blockade of epithelial sodium channels."
      },
      "correct_answer": "B",
      "explanation": "Correct Answer: B) Blockade of Na Cl symporter Explanation: Thiazide diuretics primarily exert their effects by inhibiting the Na-Cl symporter in the distal convoluted tubule (DCT) of the nephron. Na-Cl symporter normally facilitates the reabsorption of Na+ and Cl- from the filtrate back into the bloodstream. By blocking this, thiazides reduce the reabsorption of Na+ and Cl- , leading to increased excretion of these ions in the urine. This results in diuresis and a reduction in blood volume , helping to lower blood pressure and reduce edema (associated with CHF, hepatic cirrhosis, nephrotic syndrome, chronic renal failure, acute glomerulonephritis) Blockade of Na Cl symporter (Option A) : This is the mechanism of action of loop diuretics (like furosemide ), which inhibit the Na-K-2Cl symporter in the thick ascending limb of the loop of Henle, not the distal convoluted tubule. Blockade of aldosterone receptors (Option C) : This describes the mechanism of aldosterone antagonists (like spironolactone ), which block aldosterone receptors in the collecting duct and distal tubule, leading to increased sodium excretion and potassium retention. Blockade of epithelial sodium channels (Option D) : This refers to the action of amiloride , which is a potassium-sparing diuretic . They block the epithelial sodium channels in the distal convoluted tubule and collect the duct , reducing sodium reabsorption and preventing potassium loss. Reference: Goodman and Gilman's The Pharmacological Basis of Therapeutics, 14th Edition, Pages 562, 566, 567",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 20,
      "question": "A 35-year-old male experiences headache, nausea, and shortness of breath while trekking. The physician prescribes a drug to alleviate his symptoms. The drug administered primarily acts on which part of the nephron?",
      "options": {
        "A": "Proximal convoluted tubule (PCT)",
        "B": "Loop of Henle",
        "C": "Distal convoluted tubule (DCT)",
        "D": "Collecting duct (CD)"
      },
      "correct_answer": "A",
      "explanation": "of acute mountain sickness (AMS) due to hypoxia at high altitude . The drug commonly prescribed for AMS is acetazolamide , a carbonic anhydrase inhibitor , which primarily acts on the proximal convoluted tubule (PCT) of the nephron. Mechanism of Acetazolamide in AMS: Inhibits carbonic anhydrase in the PCT , leading to: Decreased bicarbonate (HCO II ) reabsorption → metabolic acidosis Increased renal excretion of bicarbonate → compensatory hyperventilation This enhances ventilation and improves oxygenation , helping alleviate AMS symptoms. Acetazolamide in AMS Symptom Alleviation Inhibits kidney carbonic anhydrase. Increases urine bicarbonate ions excretion → Metabolic acidosis. Counteracts respiratory alkalosis from high altitude hyperventilation. Improves oxygenation and alleviates AMS symptoms. Loop of Henle (Option B) is incorrect because loop diuretics (e.g., furosemide) act here by inhibiting Na I -K I -2Cl I cotransport , but they are not used for AMS. Distal Convoluted Tubule (DCT) (Option C) is incorrect because thiazide diuretics act here by inhibiting Na I -Cl I symport , but they do not correct AMS-related hypoxia. Collecting Duct (CD) (Option D) is incorrect because the collecting duct is the site of aldosterone and ADH regulation , affected by potassium-sparing diuretics (e.g., spironolactone) , which do not treat AMS. Reference: Use of acetazolamide in AMS",
      "image": null,
      "explanation_image": "https://raw.githubusercontent.com/tk22kalal/mcqimage/main/pxpharmacology/Renal_Pharmacology-Previous_Year_Questions_Q20_exp.jpg",
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 21,
      "question": "Which of the following conditions is not treated with high-ceiling diuretics?",
      "options": {
        "A": "Generalized edema",
        "B": "Cerebral edema",
        "C": "Acute pulmonary edema",
        "D": "Pulmonary hypertension"
      },
      "correct_answer": "D",
      "explanation": "medications commonly used to treat conditions characterized by fluid overload. Loop diuretics act on the ascending limb of loop of Henle, a section of the kidney tubule, to inhibit sodium and chloride reabsorption by the Na + -K + -2Cl-, leading to increased urinary output and fluid loss. They are considered the most potent diuretics available and are effective in rapidly reducing fluid volume in the body. Pulmonary hypertension, on the other hand, is a condition characterized by increased pulmonary vascular resistance in the lungs blood vessels, which can lead to symptoms such as shortness of breath and chest pain. PDE5 inhibitors like sildenafil, vardenafil or tadalafil are used for Pulmonary hypertension treatment. While loop diuretics may be used as adjunctive therapy in treating pulmonary hypertension, they are not typically used as the primary treatment for this condition. Incorrect Options: Option A - Generalized edema: Generalized edema refers to fluid accumulation in the tissues throughout the body, typically due to conditions such as heart failure, liver disease, or kidney disease. Loop diuretics are commonly used in the treatment of generalized edema. Option B - Cerebral edema: Cerebral edema is characterized by fluid accumulation in the brain, which can lead to increased intracranial pressure and neurological symptoms. Loop diuretics and osmotic diuretics are often used in conjunction with other treatments, such as corticosteroids or osmotic agents, to manage cerebral edema. Option C - Acute pulmonary edema: Acute pulmonary edema is a condition characterized by the accumulation of fluid in the lungs, typically due to heart failure. Loop diuretics are commonly used in the treatment of acute pulmonary edema to reduce fluid accumulation and improve respiratory function. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 22,
      "question": "A 30-year-old man joins a pilgrimage to a shrine at a mountain peak . At the summit, he develops tightness in the chest, associated with breathlessness and altered sensorium . Which of the following can be given for symptomatic relief?",
      "options": {
        "A": "Mannitol",
        "B": "Digoxin",
        "C": "Diltiazem",
        "D": "Acetazolamide"
      },
      "correct_answer": "D",
      "explanation": "breath and altered sensorium at the top of a mountain which is suggestive of mountain sickness. The drug that provides relief is acetazolamide . Acetazolamide is a diuretic which inhibits carbonic acid anhydrase. It increases HCO 3 excretion in the kidneys causing a metabolic acidosis that counteracts the respiratory alkalosis (caused by hyperventilation due to hypoxic conditions. This allows for better respiratory response to hypoxic conditions. Incorrect Options: Option A, B and C are not indicated in mountain sickness. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 23,
      "question": "Which one of the listed medications acts as a carbonic anhydrase inhibitor?",
      "options": {
        "A": "Acetazolamide",
        "B": "Hydrochlorothiazide",
        "C": "Furosemide",
        "D": "Mannitol"
      },
      "correct_answer": "A",
      "explanation": "anhydrase and improves salt, potassium, bicarbonate, and water excretion. Incorrect Options: Option B - Hydrochlorothiazide: Hydrochlorothiazide is a thiazide diuretic Option C - Furosemide: Furosemide is a loop diuretic Option D - Mannitol: Mannitol is an osmotic diuretic. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 24,
      "question": "What is the preferred medication for treating neurogenic diabetes insipidus?",
      "options": {
        "A": "Conivaptan",
        "B": "Vasopressin",
        "C": "Terlipressin",
        "D": "Desmopressin"
      },
      "correct_answer": "D",
      "explanation": "neurogenic diabetes insipidus, a condition characterized by impaired water balance due to decreased vasopressin (ADH) secretion. Desmopressin is a synthetic analog of vasopressin. Incorrect Options: Option A - Conivaptan : Conivaptan is a medication used for the treatment of hyponatremia but is not typically employed for neurogenic diabetes insipidus. Patients with DI are likely to develop hypernatremia. Option B - Vasopressin : Vasopressin is not commonly used for the treatment of neurogenic diabetes insipidus. Desmopressin is the preferred first choice. Vasopressin may be considered as an alternative. Option C - Terlipressin: Terlipressin is primarily used for the management of bleeding esophageal varices and hepatorenal syndrome. It is not the drug of choice for neurogenic diabetes insipidus. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    },
    {
      "q_no": 25,
      "question": "Which of the following drugs does not require dose reduction in patients with renal failure ?",
      "options": {
        "A": "Gentamicin",
        "B": "Vancomycin",
        "C": "Amphotericin B",
        "D": "Doxycycline"
      },
      "correct_answer": "D",
      "explanation": "class. It is primarily eliminated via non-renal routes, such as hepatic metabolism and fecal excretion. As a result, renal impairment does not significantly affect its clearance. Therefore, dose reduction is not typically necessary in patients with renal failure. Incorrect Options : Option A - Gentamicin: Gentamicin is an aminoglycoside antibiotic that is eliminated primarily by the kidneys. In patients with renal failure, the clearance of gentamicin is reduced, leading to an increased risk of toxicity. Therefore, dose adjustments are necessary to avoid excessive drug accumulation and potential nephrotoxicity. Option B - Vancomycin: Vancomycin is a glycopeptide antibiotic that is primarily eliminated by the kidneys. In patients with renal impairment, the clearance of vancomycin is decreased, resulting in prolonged drug exposure. Dose adjustments are necessary to maintain therapeutic levels and prevent the risk of nephrotoxicity and other adverse effects. Option C - Amphotericin B: Amphotericin B is an antifungal medication used to treat severe systemic fungal infections. It is primarily excreted by the kidneys, and renal impairment can lead to decreased clearance and increased drug levels. Dose reduction or alternative dosing strategies are often required in patients with renal failure to minimize the risk of nephrotoxicity. Reference: Prepladder Notes",
      "image": null,
      "explanation_image": null,
      "chapter_heading": "Renal Pharmacology-Previous Year Questions"
    }
  ]
}
